A pooled CRISPR/Cas9 screen to identify genes synthetically lethal with epigenetic drugs in non-small cell lung cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Heidelberg, Universität Heidelberg, Dissertation, 2022
- Schlagwort
-
Cells
CRISPR-associated protein 9
Drugs
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wer)
-
Universitätsbibliothek Heidelberg
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.11588/heidok.00031905
- URN
-
urn:nbn:de:bsz:16-heidok-319054
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weingart, Sebastian
- Klingmüller, Ursula
- Universitätsbibliothek Heidelberg
Entstanden
- 2022
Ähnliche Objekte (12)
CRISPR-Cas9 and T cells
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
CRISPR/Cas9 genome engineering in hematopoietic cells
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Synthetic lethal treatment strategies for tumor cell senescence
Direct conversion of somatic cells utilizing CRISPR/Cas9
Hypoxia-Induced Radioresistance in Human Non-Small Cell Lung Carcinoma Cell Lines
Detection and characterization of circulating tumor cells in non-small cell lung cancer
Targeting KCa3.1 to overcome erlotinib resistance in non-small cell lung cancer cells
CRISPR-Cas9 and T cells
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
CRISPR/Cas9 genome engineering in hematopoietic cells
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Synthetic lethal treatment strategies for tumor cell senescence
Direct conversion of somatic cells utilizing CRISPR/Cas9
Hypoxia-Induced Radioresistance in Human Non-Small Cell Lung Carcinoma Cell Lines
Detection and characterization of circulating tumor cells in non-small cell lung cancer
Targeting KCa3.1 to overcome erlotinib resistance in non-small cell lung cancer cells
CRISPR-Cas9 and T cells
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
CRISPR/Cas9 genome engineering in hematopoietic cells
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Synthetic lethal treatment strategies for tumor cell senescence
Direct conversion of somatic cells utilizing CRISPR/Cas9
Hypoxia-Induced Radioresistance in Human Non-Small Cell Lung Carcinoma Cell Lines
Detection and characterization of circulating tumor cells in non-small cell lung cancer